M JAMES BARRETT Insider Trading $SUPN SUPERNUS PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for M JAMES BARRETT.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of M JAMES BARRETT. M JAMES BARRETT is 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and Director in PHARMION CORP ($PHRM) and Director in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and Director in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and Director in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Liquidia Technologies Inc ($LQDA) and Director in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and Director in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and Director in Clovis Oncology, Inc. ($CLVS) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Epizyme, Inc. ($EPZM) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Zosano Pharma Corp ($ZSAN) and Director in Senseonics Holdings, Inc. ($SENS) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Surface Oncology, Inc. ($SURF).

M JAMES BARRETT in SUPERNUS PHARMACEUTICALS, INC.

Trading Symbol: SUPN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of M JAMES BARRETT: Director
Holdings: 97,355 shares
Current Value: $2,399,801
Latest Transaction: Mar 24 2016
$SUPN Market Capitalization: $1.26B
$SUPN Previous Close: $24.65

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of M JAMES BARRETT in SUPERNUS PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADAP, APPN, ARDM, ARDX, CRCM, CBIO, CERC, CLVS, EPZM, GLYC, HPTX, INHX, INWK, IOMI, ILIU, LIQDA, LOXO, MRSN, MULE, MYOG, PRTK, PHRM, RARX, RYTM, SENS, ROKA, SUPN, SURF, SYBX, TSRO, TCON, VTAE, VG, YMTX, ZSAN, ZHNE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 24 2016SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorGiftG0.0018,000097,355115.4 K to 97.4 K (-15.60 %)
Mar 03 2016SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorOption ExerciseA12.9815,000194,70015,000
Dec 08 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS14.7570,9131,045,953070.9 K to 0 (-100.00 %)
Dec 08 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS14.3871,0671,022,19270,913142 K to 70.9 K (-50.05 %)
Dec 08 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS14.5470,9901,032,152141,980213 K to 142 K (-33.33 %)
Dec 03 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.00212,9700212,9700 to 213 K
Dec 03 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.008,733024,31715.6 K to 24.3 K (+56.04 %)
Dec 03 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.0011,980033,36021.4 K to 33.4 K (+56.03 %)
Dec 03 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.0020,713057,67837 K to 57.7 K (+56.03 %)
Dec 03 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.0041,4260115,35573.9 K to 115.4 K (+56.03 %)
Dec 03 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellJ0.001,172,932001.2 M to 0 (-100.00 %)
Dec 03 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.001,172,93201,172,9320 to 1.2 M
Dec 03 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellJ0.003,820,625003.8 M to 0 (-100.00 %)
Nov 30 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorOption ExerciseM9.247,45768,9030
Nov 30 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorOption ExerciseM7.908,72268,9040
Nov 30 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS16.3516,179264,49473,92990.1 K to 73.9 K (-17.96 %)
Nov 30 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyM9.247,45768,90390,10882.7 K to 90.1 K (+9.02 %)
Nov 30 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyM7.908,72268,90482,65173.9 K to 82.7 K (+11.80 %)
Nov 18 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS16.5043,000709,543043 K to 0 (-100.00 %)
Nov 18 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS16.7150,000835,46043,00093 K to 43 K (-53.76 %)
Nov 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS16.1319,650317,03593,000112.7 K to 93 K (-17.44 %)
Nov 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS16.26100,0001,625,610112,650212.7 K to 112.7 K (-47.03 %)
Nov 12 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.00212,6500212,6500 to 212.7 K
Nov 12 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.008,728015,5846.9 K to 15.6 K (+127.30 %)
Nov 12 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.0011,974021,3809.4 K to 21.4 K (+127.30 %)
Nov 12 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.0020,703036,96516.3 K to 37 K (+127.31 %)
Nov 12 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.0041,405073,92932.5 K to 73.9 K (+127.31 %)
Nov 12 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellJ0.001,172,932001.2 M to 0 (-100.00 %)
Nov 12 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.001,172,93201,172,9320 to 1.2 M
Nov 12 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellJ0.003,820,62503,820,6257.6 M to 3.8 M (-50.00 %)
Jun 19 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS16.0248,796781,800048.8 K to 0 (-100.00 %)
Jun 19 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS16.6763,0851,051,80448,796111.9 K to 48.8 K (-56.39 %)
Jun 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellS16.8555,105928,668111,881167 K to 111.9 K (-33.00 %)
Jun 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.00166,9860166,9860 to 167 K
Jun 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.006,85606,8560 to 6.9 K
Jun 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.009,40609,4060 to 9.4 K
Jun 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.0016,262016,2620 to 16.3 K
Jun 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.0032,524032,5240 to 32.5 K
Jun 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellJ0.00921,0000921,0001.8 M to 921 K (-50.00 %)
Jun 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorBuyJ0.00921,0000921,0000 to 921 K
Jun 17 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorSellJ0.003,000,00007,641,25010.6 M to 7.6 M (-28.19 %)
Mar 05 2015SUPNSUPERNUS PHARMACEU ...BARRETT M JAMESDirectorOption ExerciseA9.1320,000182,60020,000

Page:   1